
Supporting five Japanese digital health startups in accessing medical data and developing and validating AI models
JETRO is collaborating with the Mayo Clinic Platform (operated by the Mayo Clinic, a leading U.S. medical institution) to implement an acceleration program calledHealthTech Gateway "AI Medical in the US"The "MHLW" is pleased to announce that it has selected five startups to participate in the Medical Data Utilization Program (Phase 2), which will begin in January 2025!
The three main points of this presentation are as follows
Five companies have been selected to participate in the "HealthTech Gateway "AI Medical in the US"" in collaboration with the "Mayo Clinic Platform" operated by the Mayo Clinic, a leading medical institution in the U.S., for Phase 2 (second phase) of the medical data utilization program. Five companies have been selected to participate in the second phase of the medical data utilization program, which will begin in January 2025 and provide support for approximately 30 weeks.
2. Phase 2 will provide access to the Mayo Clinic Platform's medical data platform, which will be key to the US and global expansion. In addition, product development and validation support, mentoring opportunities, etc. will be provided to solidify the foundation in the U.S.
In April 2025, the company plans to travel to the U.S. state of Minnesota to give a 5-minute pitch at a DemoDay event and network with people involved in the Minnesota ecosystem, and through these programs, the company will provide comprehensive support for entry into the U.S. market.
The basic program, Phase 1, lasted approximately 10 weeks from October to December 2024, and included knowledge acquisition for market entry, support for strategy development, and assistance in forming local connections.
This program is an acceleration program to support digital health startups, including those using AI, to enter the U.S. market in cooperation with the Mayo Clinic Platform_Accelerate, an innovation accelerator program within the Mayo Clinic, a leading medical institution in the U.S., under the cooperation of the Ministry of Economy, Trade and Industry. The program is an acceleration program to support the entry of digital health startups, including AI-based startups, into the U.S. market.
This is the first startup support program by JETRO to be an acceleration program in collaboration with a medical institution.
In the foundation program (Phase 1), which ran for about 10 weeks from October 2024, 16 selected startups were provided with knowledge acquisition and strategy development support for entering the U.S. healthcare market with the cooperation of Kicker Ventures, a venture capital firm specializing in the U.S. healthcare sector, The program also supported the startups in making local connections through visits to the Mayo Clinic Minnesota campus.
Five AI-based digital health companies have been selected through a rigorous screening process by the Mayo Clinic Platform for the medical data utilization program (Phase 2), which will begin in January 2025.
The 30-week virtual program provides comprehensive support for entering the U.S. market through access to a medical data platform with millions of de-identified data, development and validation of AI models, 1-on-1 mentoring by experts, feedback from clinical teams, and participation in pitch events for the Minnesota ecosystem and investors, including the Mayo Clinic. We provide comprehensive support for entry into the U.S. market through 1-on-1 mentoring by experts, feedback from clinical teams, and participation in pitch events for the Minnesota ecosystem and investors, including the Mayo Clinic.
Companies selected for the Medical Data Application Program: 5 companies (in alphabetical order)
interpoint (interword separation)Smart Opinion Inc.
Developed breast ultrasound image AI diagnosis support software for breast cancer. Developed an online medical platform and patient support program.
interpoint (interword separation)Splink Corporation
Develops Brain Healthcare and Medical Data Infrastructure businesses, mainly SaMD, offering CQ test®, a simple cognitive function test, and Brain Life Imaging®, an AI program for brain docks, to prevent and raise awareness of cognitive decline.
interpoint (interword separation)Ubie Corporation
Developing support services for consumers, medical institutions, and pharmaceutical companies centered on a proprietary AI medical interview engine. Provision of "Ubby," which enables users to find out the names of reference diseases and nearby medical institutions simply by answering their own symptoms. Development of "Ubi-Medical Navi," a service package for medical institutions that supports improvement of the quality of medical treatment.
interpoint (interword separation)YStory Inc.
Develops menopausal digital healthcare business using AI technology and medical science. JoyHer, a menopausal healthcare application that provides personalized care tips (advice) by tapping daily symptoms and initiatives. Aiming to become a one-stop platform for menopause awareness, diagnosis, and treatment.
interpoint (interword separation)Yuimedi Corporation
Provider of software and services for the utilization of medical data. Developed YuiQuery, an AI assistant for medical teams and data scientists that streamlines data extraction, knowledge integration and data governance.
About Japan External Trade Organization (JETRO)
JETRO aims to contribute to the further development of Japan's economy and society through trade and investment promotion and research on developing countries.
The JBIC's domestic and overseas network consists of more than 70 overseas offices and about 50 domestic offices, including the Tokyo Head Office, Osaka Head Office, the Institute of Developing Economies, and domestic offices, and it is fully utilizing this network to flexibly and efficiently support innovation creation, exports of agricultural, forestry, and fishery products and foods, and overseas expansion of small and medium enterprises (SMEs). In addition, we contribute to Japan's corporate activities and trade policy through surveys and research.
In recent years, in conjunction with the government's five-year plan for startup development, we have been strongly promoting support for startups' overseas expansion.
Japan External Trade Organization (JETRO) Startup Division|Outline
| name of company | Startup Division, Japan External Trade Organization (JETRO) |
| Location | 7F Ark Mori Building, 1-12-32 Akasaka, Minato-ku, Tokyo |
| representative | Tatsuhiko Shiono |
| uniform resouce locator | https://www.jetro.go.jp/themetop/innovation/ |









